Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection
Open Access
- 1 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (11) , 4373-4374
- https://doi.org/10.1182/blood-2004-02-0583
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesBlood, 2003
- Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimenBlood, 2002
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Effect of intra-peritoneal fludarabine on rat spinal cord tolerance to fractionated irradiationRadiotherapy and Oncology, 1995
- ENDOGENOUS STEM CELL REPOPULATION RESULTING IN MIXED HEMATOPOIETIC CHIMERISM FOLLOWING TOTAL BODY IRRADIATION AND MARROW TRANSPLANTATION FOR ACUTE LEUKEMIATransplantation, 1982
- Autogenous Recovery of Marrow FunctionArchives of internal medicine (1960), 1961